Upregulation of IGF2 expression during vascular calcification

Area of Science:

• Cardiovascular Biology
• Cellular and Molecular Medicine
• Biomineralization

Background:

• Vascular calcification involves hydroxyapatite deposition in arteries and cardiac valves, sharing similarities with skeletal mineralization.
• The precise cellular mechanisms underlying vascular calcification remain incompletely understood.

Purpose of the Study:

• To investigate the gene expression changes during vascular calcification in murine vascular smooth muscle cells (VSMCs).
• To identify key molecular players, such as Insulin-like Growth Factor 2 (IGF2), involved in the calcification process.

Main Methods:

• Microarray analysis to identify differentially expressed genes in calcifying VSMCs.
• Quantitative real-time PCR (RT-qPCR) and immunoblotting to validate IGF2 expression.
• Analysis of IGF2 expression in the Enpp1(-/-) mouse model.
• Cell-signaling studies to assess the impact of IGF2 on Akt and Erk1/2 phosphorylation.

Main Results:

• Microarray analysis revealed upregulation of over 9000 genes, with IGF2 being the most significantly differentially expressed.
• Increased IGF2 expression was confirmed in calcifying murine VSMCs and in the aorta of Enpp1(-/-) mice.
• IGF2 stimulation led to significant phosphorylation of Akt and Erk1/2 in VSMCs, indicating pathway activation.

Conclusions:

• IGF2 may mediate vascular calcification through the activation of Akt and Erk1/2 signaling pathways.
• Elevated IGF2 expression in calcifying VSMCs may relate to its known role in embryonic development and osteogenesis.
• Understanding IGF2's role is crucial for elucidating the etiology of vascular calcification.